Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Noninvasive tests of CYP3A enzymes.

× No keyword cloud information.

79 in total

1. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.

Authors: P Damkier; L L Hansen; K Brosen
Journal: Br J Clin Pharmacol Date: 1999-12 Impact factor: 4.335

2. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates.

Authors: K E Kenworthy; J C Bloomer; S E Clarke; J B Houston
Journal: Br J Clin Pharmacol Date: 1999-11 Impact factor: 4.335

3. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors: R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal: Pharm Res Date: 1999-03 Impact factor: 4.200

Review 4. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.

Authors: G R Wilkinson
Journal: J Pharmacokinet Biopharm Date: 1996-10

5. Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.

Authors: Chin B Eap; Thierry Buclin; Gianni Cucchia; Daniele Zullino; Elisabeth Hustert; Gabriela Bleiber; Kerry Powell Golay; Anne-Catherine Aubert; Pierre Baumann; Amalio Telenti; Reinhold Kerb
Journal: Eur J Clin Pharmacol Date: 2004-04-28 Impact factor: 2.953

6. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.

Authors: Nuntiya Somparn; Upa Kukongviriyapan; Wichittra Tassaneeyakul; Arunee Jetsrisuparb; Veerapol Kukongviriyapan
Journal: Eur J Clin Pharmacol Date: 2006-11-21 Impact factor: 2.953

7. CYP3A phenotypes and genotypes in North Indians.

Authors: Naushad Rais; Yogesh K Chawla; Krishan K Kohli
Journal: Eur J Clin Pharmacol Date: 2006-04-21 Impact factor: 2.953

8. Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Authors: N Widmer; L A Decosterd; C Csajka; S Leyvraz; M A Duchosal; A Rosselet; B Rochat; C B Eap; H Henry; J Biollaz; T Buclin
Journal: Br J Clin Pharmacol Date: 2006-07 Impact factor: 4.335

9. Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme.

Authors: Xue-Ding Wang; Jia-Li Li; Qi-Biao Su; Su Guan; Jie Chen; Jun Du; Yu-Wen He; Jun Zeng; Jin-Xin Zhang; Xiao Chen; Min Huang; Shu-Feng Zhou
Journal: Br J Clin Pharmacol Date: 2008-12-01 Impact factor: 4.335

10. Variability in drug metabolizing enzyme activity in HIV-infected patients.

Authors: Amanda E Jones; Kevin C Brown; Rebecca E Werner; Karl Gotzkowsky; Andrea Gaedigk; Mike Blake; David W Hein; Charles van der Horst; Angela D M Kashuba
Journal: Eur J Clin Pharmacol Date: 2010-01-19 Impact factor: 2.953